[Percutaneous intervention in left main coronary disease: medium and long term clinical outcomes in a high risk

Marta Ponte1, Ricardo Fontes-Carvalho, Rita Faria

  • 1Serviços de Cardiologia e de Cirurgia Cardio-Torácica do Centro Hospitalar de Vila Nova de Gaia/Espinho e Faculdade de Medicina da Universidade do Porto. Portugal.

Insights

Percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) disease is safe for selected patients. However, outcomes are poor for those undergoing emergent PCI or refused for surgery due to high baseline risk.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Coronary artery bypass graft (CABG) is the standard for left main coronary artery (LMCA) disease.
  • Percutaneous coronary intervention (PCI) is increasingly used for LMCA disease.
  • Assessing LMCA PCI outcomes in a cardiac surgery hospital is crucial.

Purpose of the Study:

  • To evaluate mid- and long-term clinical outcomes of LMCA PCI.
  • To compare outcomes across different indications for LMCA PCI.

Main Methods:

  • Retrospective analysis of 96 patients undergoing LMCA PCI (2005-2011).
  • Patients grouped by indication: refused surgery (G1), emergent PCI (G2), protected LMCA (G3), favorable anatomy (G4).
  • Follow-up in 100% of patients (median 21 months).

Main Results:

  • Overall mortality was 28.1% (14.6% cardiovascular).
  • Major adverse cardiovascular and cerebrovascular event (MACCE) rate was 26%.
  • Mortality was significantly higher in G1 and G2 (46.4%, 64.3%) vs. G3 and G4 (11.1%, 5.6%).

Conclusions:

  • LMCA PCI is safe with low mortality in patients with protected LMCA or favorable anatomy.
  • Emergent PCI or PCI in patients refused surgery carries a high event rate due to baseline risk.
  • PCI is a viable option for specific LMCA disease patient groups.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...